Preventive therapy in postoperative Crohn's disease

Area of Science:

• Gastroenterology
• Surgical Gastroenterology
• Inflammatory Bowel Disease Management

Background:

• Crohn's disease recurrence post-surgery is frequent, necessitating optimized management strategies.
• Current approaches for assessing, preventing, and treating postoperative recurrence require refinement.
• Recent advancements offer new insights into postoperative Crohn's disease management.

Purpose of the Study:

• To review current understanding and recent developments in managing postoperative Crohn's disease recurrence.
• To identify key predictors and effective strategies for preventing and treating disease recurrence after surgical resection.
• To explore emerging therapeutic options and future research directions.

Main Methods:

• Review of recent literature on Crohn's disease recurrence after surgery.
• Analysis of predictors for postoperative recurrence, including clinical and genetic factors.
• Evaluation of diagnostic modalities for detecting recurrence, such as ileocolonoscopy and inflammatory markers.
• Assessment of current and emerging pharmacological interventions for prevention and treatment.

Main Results:

• Key predictors of recurrence include smoking, disease behavior (penetrating), prior resections, and family history.
• Ileocolonoscopy is the gold standard for mucosal recurrence detection; stool lactoferrin/calprotectin and ultrasound show promise.
• Pharmacological options like azathioprine, 6-mercaptopurine, nitroimidazoles, and infliximab are available for postoperative use.
• Smoking cessation and early endoscopic surveillance are crucial components of postoperative care.

Conclusions:

• Smoking cessation and regular ileocolonoscopy are recommended for all patients post-surgery.
• While predictors of recurrence are known, optimal timing and selection of postoperative medications remain uncertain.
• Immunomodulators and anti-TNF agents may prevent recurrence in high-risk individuals.
• Future research should focus on personalized management based on recurrence predictors and patient genotypes/phenotypes.